EP3737750
ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
8.1.2019:
5.6.2024:
19739158.4
:
7.1.2039:
7.1.2025
:
ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS
8.1.2019
5.6.2024
7.1.2025
:
Theriva Biologics, Inc.:
9605 Medical Center Drive Suite 270, Rockville, MD 20850, US
:
KALEKO, Michael:
Rockville, MD 20850, US
:
FURLAN FREGUIA, Christian:
Rockville, MD 20850, US
:
CONNELLY, Sheila:
Rockville, MD 20850, US
:
201862615227 P:
9.1.2018:
US
:
201862679310 P:
1.6.2018:
US
:
US2019012671:
8.1.2019
:
C12N 9/16, C12Q 1/42, G01N 33/68, A23L 29/00, A61K 35/741, A61P 25/18, A61K 38/46